Portfolio Holdings Detail for ISIN IE00BMX0DF60
Stock Name / Fund iShares US Medical Devices UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker UMDV.AS(USD) CXE
ETF Ticker UMDV(USD) Euronext Amsterdam

Holdings detail for OMCL

Stock Name	Omnicell Inc
Ticker	OMCL(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US68213N1090
LEI	5493008RH0GTKHHPZI77

Show aggregate OMCL holdings

News associated with OMCL

Implied FYX Analyst Target Price: $122: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-15 07:18:24
Omnicell (NASDAQ:OMCL) & Fulgent Genetics (NASDAQ:FLGT) Head-To-Head Analysis: Omnicell (NASDAQ:OMCL – Get Free Report) and Fulgent Genetics (NASDAQ:FLGT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Risk and Volatility Omnicell has a beta of […] - 2025-09-12 05:16:53
The Zacks Analyst Blog Highlights Butterfly Network, Omnicell, NVIDIA, Palantir and IBM: Butterfly Network and Omnicell stand out as top health-tech stocks benefiting from AI, machine learning, and quantum advancements in healthcare, alongside NVIDIA, Palantir, and IBM driving transformative innovations. - 2025-09-12 04:35:00
NVIDIA, AI & Quantum Leaders Drive Health Tech: 2 Stocks to Buy: Butterfly Network and Omnicell emerge as standout health tech stocks as AI and quantum breakthroughs reshape diagnostics and medication management. - 2025-09-11 16:00:00
Brokerages Set Omnicell, Inc. (NASDAQ:OMCL) PT at $46.71: Shares of Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are currently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year […] - 2025-09-08 03:08:52
Brokerages Set Omnicell, Inc. (NASDAQ:OMCL) PT at $45.33: Shares of Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 […] - 2025-08-14 03:07:13
Federated Hermes Inc. Sells 41,248 Shares of Omnicell, Inc. (NASDAQ:OMCL): Federated Hermes Inc. decreased its stake in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 5.2% in the first quarter, HoldingsChannel reports. The institutional investor owned 746,499 shares of the company’s stock after selling 41,248 shares during the period. Federated Hermes Inc.’s holdings in Omnicell were worth $26,098,000 at the end of the most […] - 2025-08-01 04:26:49
Head to Head Review: Omnicell (NASDAQ:OMCL) vs. Schrodinger (NASDAQ:SDGR): Omnicell (NASDAQ:OMCL – Get Free Report) and Schrodinger (NASDAQ:SDGR – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, dividends, analyst recommendations and valuation. Risk & Volatility Omnicell has a beta of 0.76, […] - 2025-08-01 02:50:53
Omnicell (NASDAQ:OMCL) Given New $40.00 Price Target at Wells Fargo & Company: Omnicell (NASDAQ:OMCL – Free Report) had its price objective boosted by Wells Fargo & Company from $37.00 to $40.00 in a research note released on Monday morning,Benzinga reports. The firm currently has an overweight rating on the stock. OMCL has been the topic of a number of other research reports. Piper Sandler reaffirmed an “overweight” […] - 2025-07-22 07:12:53
Principal Financial Group Inc. Has $8.55 Million Stake in Omnicell, Inc. (NASDAQ:OMCL): Principal Financial Group Inc. boosted its position in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 2.6% during the first quarter, HoldingsChannel reports. The institutional investor owned 244,644 shares of the company’s stock after purchasing an additional 6,288 shares during the period. Principal Financial Group Inc.’s holdings in Omnicell were worth $8,553,000 at the […] - 2025-07-15 05:04:22
Omnicell, Inc. (NASDAQ:OMCL) Receives $44.83 Consensus Target Price from Brokerages: Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seven analysts that are presently covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price objective among brokers […] - 2025-06-25 03:02:58
Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Exchange Traded Concepts LLC: Exchange Traded Concepts LLC lessened its position in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 88.1% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 38,158 shares of the company’s stock after selling 281,524 shares during the quarter. Exchange Traded Concepts LLC’s holdings […] - 2025-06-19 04:58:57
Validea Kenneth Fisher Strategy Daily Upgrade Report - 6/18/2025: The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.OMNICELL INC (OMCL) - 2025-06-18 06:30:33
Two Sigma Advisers LP Has $939,000 Holdings in Omnicell, Inc. (NASDAQ:OMCL): Two Sigma Advisers LP trimmed its position in Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 11.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,100 shares of the company’s stock after selling 2,600 shares during the period. Two Sigma Advisers LP’s holdings […] - 2025-06-02 06:56:50
Nuveen Asset Management LLC Trims Stock Position in Omnicell, Inc. (NASDAQ:OMCL): Nuveen Asset Management LLC lessened its holdings in Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 22.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 179,200 shares of the company’s stock after selling 50,790 shares during the period. Nuveen Asset Management LLC owned […] - 2025-05-29 04:56:59
Omnicell, Inc. (NASDAQ:OMCL) Receives Average Recommendation of “Moderate Buy” from Brokerages: Shares of Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price […] - 2025-05-28 02:34:49
Two Sigma Investments LP Boosts Stock Position in Omnicell, Inc. (NASDAQ:OMCL): Two Sigma Investments LP increased its holdings in Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 44.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 141,738 shares of the company’s stock after purchasing an additional 43,471 shares during the quarter. Two Sigma […] - 2025-05-27 05:28:55
Omnicell, Inc. (NASDAQ:OMCL) Shares Acquired by ProShare Advisors LLC: ProShare Advisors LLC boosted its stake in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 44.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,766 shares of the company’s stock after buying an additional 4,238 shares during the quarter. ProShare Advisors […] - 2025-05-26 05:17:00
Omnicell (NASDAQ:OMCL) Price Target Raised to $34.00: Omnicell (NASDAQ:OMCL – Free Report) had its target price hoisted by Bank of America from $30.00 to $34.00 in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has a neutral rating on the stock. OMCL has been the topic of a number of other research reports. JPMorgan Chase & Co. […] - 2025-05-26 02:58:50
Omnicell (NASDAQ:OMCL) Price Target Raised to $37.00: Omnicell (NASDAQ:OMCL – Free Report) had its target price upped by Wells Fargo & Company from $35.00 to $37.00 in a research note issued to investors on Friday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock. Other equities research analysts have also issued research reports about the company. Benchmark dropped their […] - 2025-05-26 02:58:49
Northern Trust Corp Purchases 69,916 Shares of Omnicell, Inc. (NASDAQ:OMCL): Northern Trust Corp raised its holdings in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 14.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 565,026 shares of the company’s stock after acquiring an additional 69,916 shares during the period. Northern Trust Corp owned approximately 1.22% […] - 2025-05-12 04:48:57
Price T Rowe Associates Inc. MD Acquires 3,323 Shares of Omnicell, Inc. (NASDAQ:OMCL): Price T Rowe Associates Inc. MD raised its holdings in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 8.1% during the fourth quarter, HoldingsChannel reports. The fund owned 44,206 shares of the company’s stock after purchasing an additional 3,323 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in Omnicell were worth […] - 2025-05-08 04:58:56
Brokerages Set Omnicell, Inc. (NASDAQ:OMCL) Price Target at $50.67: Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) has received a consensus recommendation of “Hold” from the six analysts that are covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price target among brokers […] - 2025-05-06 03:07:10
Omnicell (NASDAQ:OMCL) Downgraded by StockNews.com to “Hold”: Omnicell (NASDAQ:OMCL – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Saturday. A number of other brokerages have also recently issued reports on OMCL. Wells Fargo & Company dropped their target price on shares of Omnicell from $40.00 to $38.00 […] - 2025-05-05 02:30:43
Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Marshall Wace LLP: Marshall Wace LLP decreased its position in Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 93.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 18,029 shares of the company’s stock after selling 245,023 shares during the period. Marshall Wace LLP’s holdings in Omnicell were worth […] - 2025-05-01 04:51:00
Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Envestnet Asset Management Inc.: Envestnet Asset Management Inc. cut its stake in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 8.5% during the fourth quarter, Holdings Channel reports. The firm owned 86,070 shares of the company’s stock after selling 7,990 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Omnicell were worth $3,832,000 at the end of […] - 2025-04-24 04:26:47
Walleye Trading LLC Purchases Shares of 7,053 Omnicell, Inc. (NASDAQ:OMCL): Walleye Trading LLC acquired a new position in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 7,053 shares of the company’s stock, valued at approximately $314,000. Several other hedge funds also recently modified their […] - 2025-04-21 06:20:53
Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Russell Investments Group Ltd.: Russell Investments Group Ltd. lessened its stake in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 6.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 105,097 shares of the company’s stock after selling 7,643 shares during the quarter. Russell Investments Group Ltd. […] - 2025-04-15 04:54:50
120,670 Shares in Omnicell, Inc. (NASDAQ:OMCL) Bought by Arrowstreet Capital Limited Partnership: Arrowstreet Capital Limited Partnership acquired a new position in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 120,670 shares of the company’s stock, valued at approximately $5,372,000. Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard […] - 2025-04-08 05:07:00
Mitsubishi UFJ Asset Management Co. Ltd. Cuts Position in Omnicell, Inc. (NASDAQ:OMCL): Mitsubishi UFJ Asset Management Co. Ltd. lowered its holdings in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 25.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 15,136 shares of the company’s stock after selling 5,069 shares during the quarter. Mitsubishi UFJ […] - 2025-04-03 04:44:56

iShares US Medical Devices UCITS ETF OMCL holdings

Date	Number of OMCL Shares Held	Base Market Value of OMCL Shares	Local Market Value of OMCL Shares	Change in OMCL Base Value	Current Price per OMCL Share Held	Previous Price per OMCL Share Held
2025-12-03 (Wednesday)	6,469	USD 261,865	USD 261,865	USD 13,067	USD 40.48	USD 38.46
2025-12-02 (Tuesday)	6,469	USD 248,798	USD 248,798	USD 15,138	USD 38.46	USD 36.12
2025-12-01 (Monday)	6,469	USD 233,660	USD 233,660	USD -2,523	USD 36.12	USD 36.51
2025-11-28 (Friday)	6,469	USD 236,183	USD 236,183	USD -971	USD 36.51	USD 36.6601
2025-11-27 (Thursday)	6,469	USD 237,154	USD 237,154	USD 0	USD 36.6601	USD 36.6601
2025-11-26 (Wednesday)	6,469	USD 237,154	USD 237,154	USD -2,199	USD 36.6601	USD 37
2025-11-25 (Tuesday)	6,469	USD 239,353	USD 239,353	USD 4,916	USD 37	USD 36.2401
2025-11-24 (Monday)	6,469	USD 234,437	USD 234,437	USD 1,553	USD 36.2401	USD 36
2025-11-21 (Friday)	6,469	USD 232,884	USD 232,884	USD 10,868	USD 36	USD 34.32
2025-11-20 (Thursday)	6,469	USD 222,016	USD 222,016	USD -1,359	USD 34.32	USD 34.5301
2025-11-19 (Wednesday)	6,469	USD 223,375	USD 223,375	USD 712	USD 34.5301	USD 34.42
2025-11-18 (Tuesday)	6,469	USD 222,663	USD 222,663	USD 1,488	USD 34.42	USD 34.19
2025-11-17 (Monday)	6,469	USD 221,175	USD 221,175	USD -6,016	USD 34.19	USD 35.12

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of OMCL by Blackrock for IE00BMX0DF60

Show aggregate share trades of OMCL

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-06 SELL -104 35.780 34.550 34.673 USD -3,606 34.98 Profit of 32 on sale
2025-11-04 BUY 52 34.700 33.075 33.238 USD 1,728 34.98
2025-10-30 SELL -159 34.295 30.880 31.221 USD -4,964 35.00 Profit of 602 on sale
2025-10-23 SELL -53 30.890 31.270 31.232 USD -1,655 35.13 Profit of 207 on sale
2025-10-22 BUY 106 30.450 31.170 31.098 USD 3,296 35.16
2025-10-20 BUY 53 30.200 30.520 30.488 USD 1,616 35.21
2025-10-16 BUY 53 30.300 30.470 30.453 USD 1,614 35.26
2025-09-25 BUY 408 30.500 30.890 30.851 USD 12,587 35.59
2025-06-27 SELL -102 29.380 29.610 29.587 USD -3,018 36.68 Profit of 723 on sale
2025-06-12 BUY 153 29.940 30.440 30.390 USD 4,650 37.21
2025-06-10 SELL -816 31.240 32.050 31.969 USD -26,087 37.31 Profit of 4,354 on sale
2025-06-09 SELL -950 31.680 31.900 31.878 USD -30,284 37.35 Profit of 5,197 on sale
2025-05-30 SELL -100 30.370 30.510 30.496 USD -3,050 37.67 Profit of 717 on sale
2025-05-19 BUY 50 27.850 28.030 28.012 USD 1,401 38.38
2025-05-09 SELL -270 25.780 26.250 26.203 USD -7,075 38.97 Profit of 3,448 on sale
2025-04-23 SELL -53 30.690 31.700 31.599 USD -1,675 40.15 Profit of 453 on sale
2025-04-17 SELL -53 30.280 30.940 30.874 USD -1,636 40.59 Profit of 515 on sale
2025-04-10 BUY 416 31.080 32.330 32.205 USD 13,397 41.12
2025-04-04 SELL -104 32.690 34.480 34.301 USD -3,567 41.57 Profit of 756 on sale
2025-04-02 SELL -104 35.460 35.510 35.505 USD -3,693 41.64 Profit of 638 on sale
2025-03-31 SELL -156 34.960 35.090 35.077 USD -5,472 41.81 Profit of 1,050 on sale
2025-03-19 SELL -51 34.700 35.040 35.006 USD -1,785 42.59 Profit of 387 on sale
2025-02-28 SELL -100 38.060 38.700 38.636 USD -3,864 44.04 Profit of 540 on sale
2025-02-05 BUY 156 44.380 47.000 46.738 USD 7,291 45.53
2025-02-04 BUY 208 43.850 43.980 43.967 USD 9,145 45.57
2025-01-29 SELL -52 44.690 45.000 44.969 USD -2,338 45.67 Profit of 36 on sale
2025-01-23 SELL -52 43.170 43.180 43.179 USD -2,245 45.87 Profit of 140 on sale
2025-01-02 SELL -100 44.320 44.860 44.806 USD -4,481 45.91 Profit of 111 on sale
2024-12-04 BUY 150 45.910 47.630 47.458 USD 7,119 45.82
2024-12-03 SELL -50 46.900 47.370 47.323 USD -2,366 45.78 Loss of -77 on sale
2024-12-02 SELL -600 47.610 47.840 47.817 USD -28,690 45.71 Loss of -1,266 on sale
2024-11-29 SELL -1,020 46.590 48.670 48.462 USD -49,431 45.67 Loss of -2,845 on sale
2024-11-27 SELL -150 48.460 48.600 48.586 USD -7,288 45.43 Loss of -473 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-06	SELL	-104	35.780	34.550	34.673	USD -3,606	34.98 Profit of 32 on sale
2025-11-04	BUY	52	34.700	33.075	33.238	USD 1,728	34.98
2025-10-30	SELL	-159	34.295	30.880	31.221	USD -4,964	35.00 Profit of 602 on sale
2025-10-23	SELL	-53	30.890	31.270	31.232	USD -1,655	35.13 Profit of 207 on sale
2025-10-22	BUY	106	30.450	31.170	31.098	USD 3,296	35.16
2025-10-20	BUY	53	30.200	30.520	30.488	USD 1,616	35.21
2025-10-16	BUY	53	30.300	30.470	30.453	USD 1,614	35.26
2025-09-25	BUY	408	30.500	30.890	30.851	USD 12,587	35.59
2025-06-27	SELL	-102	29.380	29.610	29.587	USD -3,018	36.68 Profit of 723 on sale
2025-06-12	BUY	153	29.940	30.440	30.390	USD 4,650	37.21
2025-06-10	SELL	-816	31.240	32.050	31.969	USD -26,087	37.31 Profit of 4,354 on sale
2025-06-09	SELL	-950	31.680	31.900	31.878	USD -30,284	37.35 Profit of 5,197 on sale
2025-05-30	SELL	-100	30.370	30.510	30.496	USD -3,050	37.67 Profit of 717 on sale
2025-05-19	BUY	50	27.850	28.030	28.012	USD 1,401	38.38
2025-05-09	SELL	-270	25.780	26.250	26.203	USD -7,075	38.97 Profit of 3,448 on sale
2025-04-23	SELL	-53	30.690	31.700	31.599	USD -1,675	40.15 Profit of 453 on sale
2025-04-17	SELL	-53	30.280	30.940	30.874	USD -1,636	40.59 Profit of 515 on sale
2025-04-10	BUY	416	31.080	32.330	32.205	USD 13,397	41.12
2025-04-04	SELL	-104	32.690	34.480	34.301	USD -3,567	41.57 Profit of 756 on sale
2025-04-02	SELL	-104	35.460	35.510	35.505	USD -3,693	41.64 Profit of 638 on sale
2025-03-31	SELL	-156	34.960	35.090	35.077	USD -5,472	41.81 Profit of 1,050 on sale
2025-03-19	SELL	-51	34.700	35.040	35.006	USD -1,785	42.59 Profit of 387 on sale
2025-02-28	SELL	-100	38.060	38.700	38.636	USD -3,864	44.04 Profit of 540 on sale
2025-02-05	BUY	156	44.380	47.000	46.738	USD 7,291	45.53
2025-02-04	BUY	208	43.850	43.980	43.967	USD 9,145	45.57
2025-01-29	SELL	-52	44.690	45.000	44.969	USD -2,338	45.67 Profit of 36 on sale
2025-01-23	SELL	-52	43.170	43.180	43.179	USD -2,245	45.87 Profit of 140 on sale
2025-01-02	SELL	-100	44.320	44.860	44.806	USD -4,481	45.91 Profit of 111 on sale
2024-12-04	BUY	150	45.910	47.630	47.458	USD 7,119	45.82
2024-12-03	SELL	-50	46.900	47.370	47.323	USD -2,366	45.78 Loss of -77 on sale
2024-12-02	SELL	-600	47.610	47.840	47.817	USD -28,690	45.71 Loss of -1,266 on sale
2024-11-29	SELL	-1,020	46.590	48.670	48.462	USD -49,431	45.67 Loss of -2,845 on sale
2024-11-27	SELL	-150	48.460	48.600	48.586	USD -7,288	45.43 Loss of -473 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of OMCL

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	84,348	0	167,462	50.4%
2025-09-18	77,422	0	487,987	15.9%
2025-09-17	49,202	633	193,635	25.4%
2025-09-16	63,458	7,649	97,089	65.4%
2025-09-15	81,907	0	133,579	61.3%
2025-09-12	78,391	0	160,466	48.9%
2025-09-11	72,752	71	158,563	45.9%
2025-09-10	119,218	0	186,207	64.0%
2025-09-09	57,544	0	122,926	46.8%
2025-09-08	82,918	12	128,636	64.5%
2025-09-05	73,383	0	118,721	61.8%
2025-09-04	69,126	7,281	132,034	52.4%
2025-09-03	98,856	8	161,559	61.2%
2025-09-02	85,462	1,500	157,596	54.2%
2025-08-29	84,202	0	129,963	64.8%
2025-08-28	62,617	0	103,767	60.3%
2025-08-27	47,380	13	111,459	42.5%
2025-08-26	85,232	0	151,160	56.4%
2025-08-25	83,543	0	135,228	61.8%
2025-08-22	103,481	0	411,510	25.1%
2025-08-21	94,416	0	243,459	38.8%
2025-08-20	80,888	3	172,929	46.8%
2025-08-19	81,527	0	232,793	35.0%
2025-08-18	61,006	0	170,925	35.7%
2025-08-15	63,080	50	194,806	32.4%
2025-08-14	72,263	0	324,038	22.3%
2025-08-13	38,761	0	188,300	20.6%
2025-08-12	48,532	1	178,622	27.2%
2025-08-11	59,219	3,375	181,570	32.6%
2025-08-08	58,793	230	226,983	25.9%
2025-08-07	79,681	0	121,728	65.5%
2025-08-06	75,304	0	128,023	58.8%
2025-08-05	102,333	350	156,789	65.3%
2025-08-04	127,345	0	194,901	65.3%
2025-08-01	148,863	0	216,898	68.6%
2025-07-31	224,844	48	352,485	63.8%
2025-07-30	192,177	0	378,068	50.8%
2025-07-29	93,979	0	228,111	41.2%
2025-07-28	63,397	0	209,723	30.2%
2025-07-25	95,371	35,400	150,960	63.2%
2025-07-24	90,969	19,600	167,842	54.2%
2025-07-23	39,278	0	127,217	30.9%
2025-07-22	39,896	1,507	132,469	30.1%
2025-07-21	68,490	0	260,809	26.3%
2025-07-18	42,949	0	184,182	23.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam